1. Yan DL, Pei FX, Li J, et al. Comparative study of PILF and TLIF treatment in adult degenerative spondylolisthesis. Eur Spine J. 2008; 17:1311–6.
Article
2. Park P, Foley KT. Minimally invasive transforaminal lumbar interbody fusion with reduction of spondylolisthesis: technique and outcomes after a minimum of 2 years’ follow-up. Neurosurg Focus. 2008; 25:E16.
Article
3. Schwender JD, Holly LT, Rouben DP, et al. Minimally invasive transforaminal lumbar interbody fusion (TLIF): technical feasibility and initial results. J Spinal Disord Tech. 2005; 18(Suppl):1–6.
4. Holly LT, Schwender JD, Rouben DP, et al. Minimally invasive transforaminal lumbar interbody fusion: indications, technique, and complications. Neurosurg Focus. 2006; 20:E6.
5. Park Y, Ha JW, Lee YT, et al. Minimally invasive transforaminal lumbar interbody fusion for spondylolisthesis and degenerative spondylosis: 5-year results. Clin Orthop Relat Res. 2014; 472:1813–23.
Article
6. Park Y, Ha JW, Lee YT, et al. Surgical outcomes of minimally invasive transforaminal lumbar interbody fusion for the treatment of spondylolisthesis and degenerative segmental instability. Asian Spine J. 2011; 5:228–36.
Article
7. Barbagallo GM, Piccini M, Alobaid A, et al. Bilateral tubular minimally invasive surgery for low-dysplastic lumbosacral lytic spondylolisthesis (LDLLS): analysis of a series focusing on postoperative sagittal balance and review of the literature. Eur Spine J. 2014; 23(Suppl):705–13.
Article
8. Barbagallo GM, Certo F, Sciacca G, Albanese V. Bilateral tubular minimally invasive approach for decompression, reduction and fixation in lumbosacral lythic spondylolisthesis. Neurosurg Focus. 2013; 35(Suppl):): Video 9.
Article
9. Oh CH, Ji GY, Jeon JK, et al. Slip reduction rate between minimal invasive and conventional unilateral transforaminal interbody fusion in patients with low-grade isthmic spondylolisthesis. Korean J Spine. 2013; 10:232–6.
Article
10. Min SH, Lee DH. Minimally Invasive transforaminal lumbar interbody fusion in patients with low grade spon-dylolisthesis: Comparison of the unilateral and bilateral approaches. J Korean Orthop Assoc. 2009; 44:429–35.
11. Burkus JK, Foley K, Haid RW, et al. Surgical interbody research group-radiographic assessment of interbody fusion devices: fusion criteria for anterior lumbar interbody surgery. Neurosurg Focus. 2001; 10:E11.
Article
12. Pan J, Li L, Qian L, et al. Spontaneous slip reduction of low-grade isthmic spondylolisthesis following circumfer-ential release via bilateral minimally invasive transforaminal lumbar interbody fusion: technical note and short-term outcome. Spine (Phila Pa 1972). 2011; 36:283–9.
13. Tsahtsarlis A, Wood M. Minimally invasive transforaminal lumbar interbody fusion and spondylolisthesis. J Clin Neu-rosci. 2012; 19:858–61.
Article
14. Tay KS, Bassi A, Yeo W, et al. Intraoperative reduction does not result in better outcomes in low-grade lumbar spon-dylolisthesis with neurogenic symptoms after minimally invasive transforaminal lumbar interbody fusion-a 5-year follow-up study. Spine J. 2016; 16:182–90.
Article
15. Wegmann K, Gundermann S, Siewe J, et al. Correlation of reduction and clinical outcome in patients with degenerative spondylolisthesis. Arch Orthop Trauma Surg. 2013; 133:1639–44.
Article
16. Benli IT, Ciç ek H, Kaya A. Comparison of sagittal plane realignment and reduction with posterior instrumentation in developmental low or high dysplastic spondylolisthesis. Kobe J Med Sci. 2006; 52:151–69.
17. Scheufler KM, Dohmen H, Vougioukas VI. Percutaneous transforaminal lumbar interbody fusion for the treatment of degenerative lumbar instability. Neurosurgery. 2007; 60(Suppl):203–12.
Article
18. Wang J, Zhou Y, Zhang ZF, et al. Comparison of one-level minimally invasive and open transforaminal lumbar interbody fusion in degenerative and isthmic spondylolisthesis grades 1 and 2. Eur Spine J. 2010; 19:1780–4.
Article
19. Wu RH, Fraser JF, Hä rtl R. Minimal access versus open transforaminal lumbar interbody fusion: meta-analysis of fusion rates. Spine (Phila Pa 1972). 2010; 35:2273–81.